Dear colleagues.
is well-known use of erythropoietin for neuroprotection HIE during therapeutic hypothermia. It is used in neonates of 35 weeks or more
Unfortunately infants less than 35 weeks also sometimes suffer asphyxia and implementation HIE
What recommendations has the use of erythropoietin in such cases?